Statutory Health Insurance Funds
- Prescription of medicinal products and medical devices for reimbursement by the statutory health insurance system
- Pricing of medicinal products
- Advice on early benefit assessment by the Federal Joint Committee (G-BA) and support in negotiations on reimbursement amounts with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband)
- Health Technology Assessment – HTA – in the cost/benefit assessment in accordance with the German Social Code (SGB V)
- Discount agreements between health insurance companies and service providers
- Cartel law and public procurement law in the statutory health insurance system
- Appeals against measures of health insurance companies, associations of statutory health insurance physicians and Federal Joint Committee (GBA)
- Proceedings concerning the cutting of physicians’ fees and recourse proceedings against physicians